Cargando…
SLC17A9 expression levels in a pan‑cancer panel and validation of the role of SLC17A9 as a novel prognostic biomarker for osteosarcoma
Previous studies have demonstrated the involvement of the solute carrier family 17 member 9 (SLC17A9) in certain types of cancer; however, the precise role of SLC17A9 is not well defined. In the present study, a comprehensive analysis was performed to determine the involvement of SLC17A9 in a pan-ca...
Autores principales: | Li, Junqing, Wu, Feiran, Su, Li, Zhu, Huimin, Yao, Jie, Zhang, Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407858/ https://www.ncbi.nlm.nih.gov/pubmed/37559587 http://dx.doi.org/10.3892/ol.2023.13969 |
Ejemplares similares
-
Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma
por: Kui, Xue-Yan, et al.
Publicado: (2022) -
Expression of SLC17A9 in hepatocellular carcinoma and its clinical significance
por: Wu, Jingdong, et al.
Publicado: (2020) -
VNUT/SLC17A9, a vesicular nucleotide transporter, regulates osteoblast differentiation
por: Inoue, Asako, et al.
Publicado: (2020) -
SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma
por: Li, Weiquan, et al.
Publicado: (2022) -
SLC1A1, SLC16A9, and CNTN3 Are Potential Biomarkers for the Occurrence of Colorectal Cancer
por: Zhou, Jie, et al.
Publicado: (2020)